Poster Abstract Session:
51. Antimicrobial Stewardship: Interventions to Improve Outcomes
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID


Presentations:
195
The Effect of Two Antibiotic Stewardship Interventions in a Telemedicine Practice
Ian Tong, MD; Kristin Dean, MD; Daniel Park, MPH; James Thompson, BS; Lily Yan, MD; Cindy Liu, MD, PhD, MPH; Rana Hamdy, MD, MPH, MSCE
196
Public Health Can Play a Role Implementing a Successful Outpatient Antimicrobial Stewardship in Primary and Urgent Care
Kelsey OYong, MPH; James A. McKinnell, MD; Chelsea Foo, MPH; Stacy Hartmann, MPH; Dawn Terashita, MD, MPH
197
Implementation of a Prospective, Pharmacist-Led Methicillin-Resistant Staphylococcus aureus Nasal PCR Screening Pilot Protocol to Reduce Overutilization of Vancomycin
Jessica Miller, Pharm.D.; Erik LaChance, Pharm.D.; Jill Starykowicz, Pharm.D., BCCCP; Sarah M. Wieczorkiewicz, Pharm.D., BCPS AQ-ID
198
Pharmacist-Led Antimicrobial Prompting During Interdisciplinary Team Rounds As a Novel Antimicrobial Stewardship Intervention
Alisha Skinner, MD; Heather Young, MD; Kati Shihadeh, PharmD; Bryan Knepper, MPH, MS, CIC; Timothy C. Jenkins, MD
Posters
  • Pharmacist Prompting Poster.pdf (758.3 kB)
  • 199
    The Urgent Need for Urgent Care Antimicrobial Stewardship: Evaluating Prescribing and Patient Outcomes Associated with a Pharmacist-led Stewardship Program
    Lauren Fay, PharmD; Lauren Wolf, PharmD, BCPS; Kasey Brandt, PharmD, BCPS; G. Robert Deyoung, PharmD, BCPS; Adam Anderson, MD, FACEP; Nnaemeka Egwuatu, MD, MPH; Lisa Dumkow, PharmD, BCPS
    Posters
  • ID Week Poster_Fay_Final1.pdf (443.3 kB)
  • 201
    Outcomes of an Antibiotic Stewardship Team at an Academic Medical Center: 11 Years of Experience
    Susan Kline, MD, MPH, FSHEA, FIDSA; Kimberly Boeser, PharmD, BCPS AQ-ID; Pamela Phelps, Pharm D; Samantha Saunders, MPH; Kari Gand, MPH, BBA; Jeana Houseman, MHSA, DLM(ASCP), CIC; Shawnda Johnson, BA
    202
    Implementation and Three-Year Results of Antimicrobial Stewardship Program in a Three Hospital Community Health System
    Nikunj Vyas, PharmD, BCPS; Cindy Hou, DO, MA, MBA, FACOI; Marianne Kraemer, RN, MPA, ED.M., CENP, CCRN; David Condoluci, DO, MACOI; Deborah Cunningham, MT HHS, BA; Sungwook Kim, Ph.D.
    Posters
  • ID Week ASP Poster 2018.pdf (709.6 kB)
  • 203
    Impact of an Infectious Diseases Fellow-Led Antimicrobial Stewardship Initiative in a Medical/Surgical ICU
    Ann Palmer, MD; Ulysses Wu, MD; Prashant Grover, MD; Dora Wiskirchen, PharmD
    Posters
  • Slide1.jpg (130.2 kB)
  • 204
    Impact of Education and Data Feedback Interventions on Outpatient Prescribing for Urinary Tract Infections
    Jason Funaro, PharmD; Rebekah W. Moehring, MD, MPH; Siyun Yang, MS; Hui-Jie Lee, PhD; Christina Sarubbi, PharmD; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA; Rebekah Wrenn, PharmD
    Posters
  • Funaro_IDWeekPoster_Final.pdf (308.7 kB)
  • 205
    Reduction of Antibiotic Prescribing within a Veterans Affairs Emergency Department through Peer Comparison
    Rameez Phulpoto, MD; Nathan R. Shively, MD; Deanna J. Buehrle, PharmD; Cornelius J. Clancy, M.D.; Brooke K. Decker, MD, CIC
    206
    Respiratory Viral Testing is Associated with Lower Frequency of Antibiotic Prescribing for Acute Upper Respiratory Infections at a Large Ambulatory Cancer Center
    Elizabeth M. Krantz, MS; Erica Stohs, MD, MPH; Ania Sweet, PharmD; Jacqlynn Zier, BA; Sara Marquis, MPH; John Klaassen, BA; Steven Pergam, MD, MPH, FIDSA; Catherine Liu, MD, FIDSA
    207
    Impact of Educational Interventions on Antibiotic Prescribing for Acute Upper Respiratory Tract Infections in the Ambulatory Care Setting
    Kaitlyn Craddock, PharmD; Suzanne Molino, PharmD, BCPS; Paul M. Stranges, PharmD, BCPS, BCACP; Katie J. Suda, PharmD, M.S.; Thomas Kannampallil, PhD; Jonathan Radosta, MD; John Hickner, MD; Nancy L. Shapiro, PharmD, BCACP; Susan C. Bleasdale, MD; Alan E. Gross, PharmD, BCPS-AQ ID
    208
    Trends in Antibiotic Prescribing for Acute Respiratory Tract Infections and Implementation of a Provider-Directed Intervention Within the Veterans Affairs Healthcare System (VA)
    Karl Madaras-Kelly, PharmD, MPH; Hayli Hruza, MPH; Benjamin Pontefract, PharmD; Barbara Jones, MD; Makoto Jones, MD, MS; Yiwen Yao, MStat; McKenna Nevers, MS; Jian Ying, PhD; Ben Haaland, PhD; Chad Kay, Pharm. D; Melissa Christopher, PharmD; Matthew Samore, MD, FSHEA
    209
    Impact of a risk-based CAP prescribing guideline paired with antimicrobial stewardship to improve antibiotic prescribing for patients at low risk for drug resistant pathogens
    Caroline Cruce, PharmD; Michael Postelnick, RPh BCPS AQ ID; David Martin, PharmD, BCPS; Sarah Sutton, MD; Richard G. Wunderink, MD; Teresa Zembower, MD, MPH, FIDSA; Marc H. Scheetz, PharmD, MSc, BCPS AQ-ID; Nathaniel J. Rhodes, PharmD, MSc, BCPS
    210
    Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza
    Jonathan Williams, MD; Nicholas Mercuro, PharmD; Amit Vahia, M.D., M.P.H.; Hira Rizvi, MD; Mujtaba Hameed, BS*; Odaliz Abreu-Lanfranco, MD; Pallavi Bhargava, MD; Linoj Samuel, PhD., D(ABMM); George Alangaden, MD, FIDSA
    Posters
  • Influenza PCR Poster.pdf (320.9 kB)
  • 212
    Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Initiative on Pneumonia Treatment at an Academic Teaching Hospital
    Jeffrey C. Pearson, PharmD; Monica V. Mahoney, PharmD, BCPS-AQ ID; Graham M. Snyder, MD, SM; Howard S. Gold, MD, FIDSA; Parth V. Patel, BSN, RN; Christopher McCoy, PharmD, BCPS-AQ ID
    213
    Multi-centered Evaluation of an Acute Respiratory Tract Infection Audit-Feedback Intervention: Impact on Antibiotic Prescribing Rates and Patient Outcomes
    Karl Madaras-Kelly, PharmD, MPH; Hayli Hruza, MPH; Benjamin Pontefract, PharmD; Robert Mckie, MD; Christopher Hostler, MD, MPH; Mary Townsend, PharmD, AAHIVP; Emily M. Potter, PharmD; Emily Spivak, MD, MHS; Sarah Hall, MD; Matthew Goetz, MD; McKenna Nevers, MS; Jian Ying, PhD; Ben Haaland, PhD; Katherine Fleming-Dutra, MD; Matthew Samore, MD, FSHEA
    214
    Antimicrobial Usage and Outcomes following Laboratory Suppression of Antimicrobial Susceptibility Results for Pseudomonas aeruginosa in Sputum Cultures
    Kwee Chin Liew, MBBS / Bachelor of Medical Sciences (1st Class Honors); Oliver Evans, MBBS; Erica Wales, MD; Stuart Bond, PhD; Peter Newton, MBBS, FRCPA; Spiros Miyakis, MD, PhD, FRACP
    Posters
  • PSEUDOMONAS.pdf (66.9 kB)
  • 216
    Step-down Therapy with Oral Fluoroquinolones vs. Oral Beta-Lactams for Hospitalized Adult Patients with Community-Acquired Pneumonia: A Multi-Hospital Cohort Study
    Lindsay Petty, M.D.; Twisha S. Patel, PharmD, BCPS; Anna Conlon, PhD; Daniel Nielsen, MS; Valerie Vaughn, MD, MSc; Keith Kaye, MD, MPH; Anurag Malani, MD, FIDSA; Danielle Osterholzer, MD; Rama Thyagarajan, MD; Scott Flanders, M.D.; Tejal Gandhi, MD
    217
    Bang for the Buck: Lessons Learned from An Ambulatory Stewardship Pilot to Reduce Excess Antibiotic Prescribing for Adult Upper Respiratory Infections
    Jaimie Mittal, MD; Kelsie Cowman, MPH; Abel Infante, -; Paul Meissner, MSPH; Asif Ansari, MD; Priya Nori, MD; Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA
    218
    IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
    Wenjing Wei, PharmD; Norman Mang, PharmD; Jessica Ortwine, PharmD; Kristin Alvarez, PharmD; Bonnie Prokesch, MD
    220
    Taking Off with Antimicrobial Intervention Rounds (AIR): Successes of a Pilot Stewardship Service at a Tertiary-Care VA Medical Center
    Ukwen Akpoji, Pharm.D., BCPS; Roberto Viau Colindres, M.D.; Robin Jump, M.D., Ph.D.; Usha Stiefel, M.D.
    221
    Save the Quinolones! Impact of a Non-Restrictive Fluoroquinolone Reduction Initiative on Antibiotic Resistance at an Urban Teaching Hospital
    Steven Smoke, PharmD; Slava Plotkin, PharmD; Neeki Patel, PharmD; Adriana Grigoriu, MD; Maria DeVivo, PharmD
    Posters
  • 221_IDWeek 2018 Poster.pdf (938.2 kB)
  • 223
    Impact of Different Stewardship Strategies Applied to a Single Antibiotic Over Time
    Katherine Lusardi, PharmD, BCPS-AQ ID; Ryan Dare, MD, MS
    224
    Cost Analysis of a Significant Decrease in Vancomycin Use as a Result of an Antimicrobial Stewardship Intervention
    Hayley Hodgson, PharmD; Paul O'Donnell, PharmD; Sarah Won, MD, MPH; Sheila K. Wang, PharmD, BCPS
    226
    An Emergency Department Antimicrobial Stewardship Intervention to Improve Antibiotic Selection and Duration for Skin and Soft Tissue Infections in Adult and Pediatric Outpatients
    Larissa May, MD, MSPH; Dan Tancredi, PhD; Benjamin Mooso, MS; Megan Nguyen, PharmD; Susan Ondak, MD; Chance Anderson, MS; Jennifer Briggs, PharmD; Linh Luong, BS; Loren G. Miller, MD, MPH
    228
    Impact of Early Alert to Antimicrobial Stewardship Interventions with the Prospective Audit and Feedback Strategy
    Sarah Si Lin Tang, BSc (Pharm) (Hons); Lun Yi Tan, BSc; Daphne Yah Chieh Yii, BPharm; Andrea L. Kwa, PharmD; Piotr Chlebicki, MBBS
    Posters
  • Bizlive poster.pdf (591.3 kB)
  • 229
    The Role of Antimicrobial Stewardship Program on Appropriate Use, Dose and Duration of Vancomycin Treatment
    Olga Kaplun, MD; Melinda Monteforte, PharmD; Samad Tirmizi, PharmD; Mersema Abate, MD; George Psevdos Jr., MD; Roderick Go, DO
    Posters
  • Vancomycin IDSA.pdf (623.3 kB)
  • 230
    Characterization of Antibiotic Timeout Program Strategies Across The United States
    Doaa Aljefri, PharmD, MSc; Caroline Cruce, PharmD; Patrick Kinn, PharmD, MPH; Kristi Kuper, PharmD, BCPS; Lucas T Schulz, PharmD, BCPS (AQ-ID); Erin K. McCreary, PharmD, BCPS; Michael Postelnick, RPh BCPS AQ ID
    231
    Facilitating the Everyday Steward: Impact of Mandatory Antimicrobial Indication/Duration and a 48 Hour Time Out
    Ann Wirtz, PharmD; Alaina Burns, PharmD; Brian R. Lee, MPH, PhD; Tammy Frank, RPh, CPHIMS; Laura Fitzmaurice, MD; Richard Ogden, PharmD, MBA, BCPS; Brian O'Neal, PharmD, MS, FASHP; Jennifer Goldman, MD, MS
    232
    Do Antibiotic Timeouts Improve Antibiotic Utilization?
    Patrick Kinn, PharmD, MPH; Michael Postelnick, RPh BCPS AQ ID; Kristi Kuper, PharmD, BCPS; Amanda Gibson, PharmD; Amy Pakyz, PharmD, MS, PhD; Lucas T Schulz, PharmD, BCPS (AQ-ID)
    233
    Evaluation of an Antimicrobial Time-Out on Antimicrobial Utilization at a Large Health System
    Steven Richardson, PharmD; Elizabeth Neuner, PharmD, BCPS (AQ-ID); Vasilios Athans, PharmD, BCPS; Pavithra Srinivas, PharmD, BCPS; Jill Wesolowski, PharmD; Steven Gordon, MD; Thomas Fraser, MD
    234
    Improving antimicrobial prescribing and rate of infectious diseases consult utilizing a best-practice alert and targeted education for Staphylococcus aureus bacteremia
    Katherine Yang, PharmD; Tejal Gandhi, MD; Chris Zimmerman, PharmD; Robert Chang, MD, FACP, SHFM; Jerod Nagel, PharmD, BCPS
    Posters
  • ID Week SAB BPA Poster.pdf (5.6 MB)
  • 235
    If Symptoms Aren’t Described, Antibiotics Aren’t Prescribed: Implementation of a Multifaceted Toolkit Targeting Overtreatment of Asymptomatic Bacteriuria across a Large Health-system
    Julie E. Williamson, PharmD; Andrea Y. Logan, PharmD; M. Sean Boger, MD, PharmD; Steven Jarrett, PharmD; Stephanie J. Irausquin, PhD; Lisa Davidson, MD
    236
    The Impact of Earlier Intervention by an Antimicrobial Stewardship Team on Appropriate Antimicrobial Therapy for Specific Antimicrobial Agents
    Daiki Hagiwara, PhD; Keisuke Sato, PhD; Mitsuhiro Kamada, PhD; Norihiro Moriwaki, PhD; Takafumi Nakano, PhD; Shouichi Shiotsuka, PhD; Hidetoshi Kamimura, PhD; Atsushi Togawa, MD, PhD; Yasushi Takamatsu, MD, PhD; Tohru Takata, MD, PhD
    Posters
  • IDWeek2018 Takata.pdf (1.1 MB)
  • 237
    Antibiotic Assessment at Discharge-Room for Stewardship Intervention
    Prakash Balasubramanian, MD; Paul Lata, PharmD; Meredith Peters, MD; Christopher Crnich, MD, PhD; Susanne Barnett, PharmD
    Posters
  • MAD VA Outpt rx.pdf (971.3 kB)
  • 238
    Sharing unit specific stewardship metrics with front-line providers to improve antibiotic prescribing
    Nicholas J Mercuro, PharmD; Rachel Kenney, PharmD; Raghavendra Vemulapalli, MD; Mariam Costandi, MD; Berta Rezik, MD; Charles T Makowski, PharmD; Susan L Davis, PharmD
    239
    Implementation of a Vertical Antimicrobial Stewardship Intervention for Patients Colonized with Clostridium difficile
    Sara Revolinski, PharmD, BCPS; Christina Tran, PharmD; Angela Huang, PharmD, BCPS-AQ ID; Njeri Wainaina, MD; L. Silvia Munoz-Price, MD, PhD
    242
    Evaluating the Effectiveness of Antimicrobial Restriction at an Academic Medical Center
    Andrew Kirk, BS; Kimberly Lee, PharmD; John Markley, DO; Amy Pakyz, PharmD, MS, PhD; Gonzalo Bearman, MD, MPH, FSHEA; Michelle Doll, MD, MPH; Michael Stevens, MD, MPH
    243
    Prioritization of Antibiotic Administration for STAT Orders in the Septic Patient: A Retrospective Analysis
    Stefanie Lam, MSc, PharmD; Zong Heng Shi, PharmD candidate; Nikki Kampouris, BPharm, MSc; Renaud Roy, PharmD, MSc.; Marty Teltscher, MDCM, FRCPC
    244
    Impact of Antibiotic Susceptibility Reporting on Broad-Spectrum Antibiotic Use in Serratia and Morganella Bacteremia
    Wendy Hui Wen Ng, BSc (Pharm) (Hons); Joy Yong, BSc (Pharm) (Hons), BCPS; Ka Lip Chew, MBBS, B. Med. Sci. FRCPath; Janice Li, MClin Pharm, BCPS
    Posters
  • IDWeek_244_final_printed.pdf (682.8 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.